LUCD – lucid diagnostics inc. (US:NASDAQ)
Stock Stats
News
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock [TheStreet.com]
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
Lucid Diagnostics (LUCD) had its price target raised by Ascendiant Capital Markets from $8.25 to $9.00. They now have a "buy" rating on the stock.
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Form PRE 14A Lucid Diagnostics Inc. For: Apr 20
Form 3 Lucid Diagnostics Inc. For: Mar 23 Filed by: Lee Victoria Tou-ho
Form S-8 Lucid Diagnostics Inc.
Form S-8 Lucid Diagnostics Inc.
Form EFFECT Lucid Diagnostics Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.